SEMA3C and cancer: Given that SEMA3C has been demonstrated to drive stemness in other cancers [6], and the fact that cancer stem cells in pancreatic tumors are thought to be responsible for chemoresistance [110], it would be interesting to explore whether SEMA3C’s ability to induce stemness extends to the context of pancreatic cancer.